This week James is joined by Dr Mark Kotter, a stem cell biologist and neurosurgeon at the University of Cambridge. He is the founder and CEO of bit.bio, who have developed opti-ox, a benchmark technology for the efficient and consistent production of human cells for use in research, drug development, and cell therapy. He also founded cultured meat startup Meatable.
Get in touch with Mark : info@bit.bio
Subscribe to Healthtech Pigeon π¦: www.healthtechpigeon.com
Get in touch: www.jamessomauroo.com | www.somx.co.uk
This week James is joined by Dr Mark Kotter, a stem cell biologist and neurosurgeon at the University of Cambridge. He is the founder and CEO of bit.bio, who have developed opti-ox, a benchmark technology for the efficient and consistent production of human cells for use in research, drug development, and cell therapy. He also founded cultured meat startup Meatable.
Get in touch with Mark : info@bit.bio
Subscribe to Healthtech Pigeon π¦: www.healthtechpigeon.com
Get in touch: www.jamessomauroo.com | www.somx.co.uk
The Healthtech Podcast covers the latest in health and technology through interviews with disruptive healthtech startups and leaders. Whether youβre a patient, founder, investor or simply interested in healthtech, The Healthtech Podcast has it covered.
π Listeners in over 150 countries.
π New episode every week.
π£ Hosted by Dr James Somauroo.
www.thehealthtechpodcast.com | www.somx.health | www.jamessomauroo.com